
Big Law Gets Shot In the Arm from Drugmakers’ Deal Spree (1)
A group of Big Law’s best-known M&A brands pitched in on a pair of newly announced pharmaceutical deals, the latest in what’s been a year full of major deal work for large firms working in this space.